B. Jones

发表

V. Knott, C. Mahoney, A. Labelle, 1999, Schizophrenia Research.

Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

V. Knott, C. Mahoney, A. Labelle, 2001, Schizophrenia Research.

Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.

M. Hayden, R. Lam, B. Jones, 1988, The Journal of clinical psychiatry.

Interaction of ginseng with phenelzine.

B. Jones, A. M. Runikis, 1987, Journal of clinical psychopharmacology.

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

B. Jones, G. Chouinard, 1980, The American journal of psychiatry.

PSYCHOSIS ASSOCIATED WITH WATER INTOXICATION: PSYCHOGENIC POLYDIPSIA OR CONCOMITANT DOPAMINERGIC SUPERSENSITIVITY DISORDERS?

B. Jones, 1984, The Lancet.

Clozapine: Current Status and Role in the Pharmacotherapy of Schizophrenia

G. Remington, P. Lalonde, B. Jones, 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.

B. Jones, K. Meehan, C. Taylor, 2001, The Journal of clinical psychiatry.

Weight change and atypical antipsychotic treatment in patients with schizophrenia.

B. Jones, B. Kinon, B. Basson, 2001, The Journal of clinical psychiatry.

Neuroleptic-induced supersensitivity psychosis.

B. Jones, G. Chouinard, L. Annable, 1978, The American journal of psychiatry.

Evidence of Brain Dopamine Deficiency in Schizophrenia

B. Jones, G. Chouinard, 1979, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

SCHIZOPHRENIA AS DOPAMINE-DEFICIENCY DISEASE

B. Jones, G. Chouinard, 1978, The Lancet.

Free Radicals and Tardive Dyskinesia

B. Jones, C. Shriqui, 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Lack of tolerance to long‐term neuroleptic treatment in dopamine tuberoinfundibular system

B. Jones, G. Chouinard, L. Annable, 1981, Acta psychiatrica Scandinavica.

Open trial of S-adenosylmethionine for treatment of depression.

M. Tohen, B. Cohen, B. Jones, 1984, The American journal of psychiatry.

Clozapine in the Treatment of Refractory Schizophrenia: Canadian Policies and Clinical Guidelines*

P. Lalonde, B. Jones, D. Addington, 1992, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Complications of tardive dyskinesia: a review.

B. Jones, R. Yassa, 1985, Psychosomatics.

Adolescent murderers.

A. Labelle, B. Jones, J. Bradford, 1991, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study.

G. Remington, B. Jones, D. Addington, 1993, Clinical therapeutics.

Age of onset in familial and sporadic schizoph4.4.renia

M. Alda, A. Labelle, B. Jones, 1996, Acta psychiatrica Scandinavica.

Risperidone Treatment for Severe Negative Symptoms

A. Labelle, B. Jones, S. Purdon, 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Drs. Chouinard and Jones Reply

B. Jones, G. Chouinard, 1980 .

A case report of risperidone-induced obsessive-compulsive symptoms.

B. Jones, K. Alzaid, 1997, Journal of clinical psychopharmacology.

Hypofrontality in Schizophrenia

B. Jones, B. Jones, 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Tardive Dyskinesia: Legal and Preventive Aspects *

B. Jones, J. Bradwejn, C. Shriqui, 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.

B. Jones, J. Bradwejn, L. Annable, 1992, The American journal of psychiatry.

Withdrawal symptoms after long-term treatment with low-potency neuroleptics.

B. Jones, G. Chouinard, J. Bradwejn, 1984, The Journal of clinical psychiatry.

Intramuscular Olanzapine and Intramuscular Haloperidol in Acute Schizophrenia: Antipsychotic Efficacy and Extrapyramidal Safety during the First 24 Hours of Treatment

I. Bitter, S. Lindborg, B. Jones, 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A pilot study of the safety and tolerance of SCH 39166 in patients with schizophrenia.

D. Naber, A. Labelle, B. Jones, 1998, Journal of psychiatry & neuroscience : JPN.

Risperidone in the Treatment of Pervasive Developmental Disorder

A. Labelle, B. Jones, S. Purdon, 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Plasma concentration of neuroleptic and serum prolactin in patients chronically receiving depot fluphenazine: No evidence of tolerance

B. Cohen, B. Jones, G. Chouinard, 1987 .

Risperidone Treatment of Bipolar Disorder

R. McIntyre, B. Jones, G. Hasey, 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Huntington's disease: pathogenesis, diagnosis and treatment.

E. Mohr, B. Jones, S. Purdon, 1994, Journal of psychiatry & neuroscience : JPN.

EEG Hemispheric Asymmetry as a Predictor and Correlate of Short-term Response to Clozapine Treatment in Schizophrenia

V. Knott, C. Mahoney, A. Labelle, 2000, Clinical EEG.

Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule.

B. Jones, G. Chouinard, A. Ghadirian, 1978, Canadian Medical Association journal.

Dissolution Profile, Tolerability, and Acceptability of the Orally Disintegrating Olanzapine Tablet in Patients with Schizophrenia

P. Chue, B. Jones, R. Dickson, 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Death attributed to ventricular arrhythmia.

B. Jones, G. Chouinard, 1979, Canadian Medical Association journal.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

A Labelle, G. Remington, D. Bloom, 1993, Journal of clinical psychopharmacology.

EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.

V. Knott, C. Mahoney, A. Labelle, 2002, Experimental and clinical psychopharmacology.

Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus.

B. Jones, G. Chouinard, 1985, The American journal of psychiatry.

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

A Labelle, E. Stip, G. Tollefson, 2000, Archives of general psychiatry.

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states

D. Naber, A. Labelle, B. Jones, 1995, Psychopharmacology.

Cotherapy behavior, group therapy process, and treatment outcome.

B. Jones, W. Piper, B. Doan, 1979, Journal of consulting and clinical psychology.

Dr. Jones Replies

B.D. Jones, B. Jones, 1982 .

Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia

Charles M Beasley, J. Mintzer, B. Jones, 2002, Neuropsychopharmacology.

Characteristics of clients with schizophrenia who express certainty or uncertainty about continuing treatment with depot neuroleptic medication.

B. Jones, A. O'Connor, B. Jones, 1997, Archives of psychiatric nursing.

Potentiation of lithium by tryptophan in a patient with bipolar illness.

S. Young, B. Jones, G. Chouinard, 1979, The American journal of psychiatry.

Early diagnosis of water intoxication by monitoring diurnal variations in body weight.

B. Jones, R. Ancill, J. Paredes, 2006, The American journal of psychiatry.

Sex differences and tardive dyskineasia.

B. Jones, G. Chouinard, L. Annable, 1980, The American journal of psychiatry.

Fast-cycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant.

B. Jones, G. Chouinard, S. Steinberg, 1984, The American journal of psychiatry.

A controlled dose‐ranging study of remoxipride and haloperidol in schizophrenia ‐ a Canadian multicentre trial

C. Durand, P. Sandor, B. Jones, 1990, Acta psychiatrica Scandinavica. Supplementum.

Tardive Dyskinesia Uncovered After Ingestion of Sominex, an Over-the-Counter Drug

S. Lal, B. Jones, 1985, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine

G. Remington, E. Stip, S. Dursun, 2003, Journal of clinical psychopharmacology.

High neuroleptic plasma levels in patients manifesting supersensitivity psychosis.

B. Jones, G. Chouinard, J. Bradwejn, 1982, Biological psychiatry.

Olanzapine versus risperidone and haloperidol in treatment of schizophrenia

G. Tollefson, B. Jones, 1998, Schizophrenia Research.

An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients.

B. Jones, G. Chouinard, J. Bradwejn, 1985, Psychopharmacology bulletin.

Early onset of tardive dyskinesia: case report.

B. Jones, G. Chouinard, 1979, The American journal of psychiatry.

Effect of carbamazepine on neuroleptic plasma levels and efficacy.

B. Jones, M. Erickson, M. Kusalic, 1986, The American journal of psychiatry.

Tardive dysmentia : further comments.

B. Jones, 1985, Schizophrenia bulletin.

Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.

B. Jones, G. Chovinard, 1982, Journal of Clinical Psychopharmacology.

Treatment of chronic schizophrenic patients.

B. Jones, 1988, Journal of clinical psychopharmacology.